Company: Siwa Therapeutics
Job title: CEO, Co-Founder & CSO
Lewis S. Gruber is the co-founder and CEO of SIWA Therapeutics, Inc. Prior to SIWA, he was interim CEO of a company developing a natural killer cell line product; he resigned to found SIWA. He also co-founded and was CEO of Arryx, Inc. (acquired by a publicly-held company). While CEO, Arryx received awards including World Economic Forum Technology Pioneer (2005) and Red Herring Top 100 Innovator (2004). From 1994 to 2000, he was CEO of Hyseq, Inc. While its CEO, Hyseq completed an IPO (1997 Salomon Inc.). He is the inventor of all SIWA patents and many others.
SIWA’s Humanized Monoclonal Antibody 3:45 pm
• Harnessing the immune system to target cancer and senescent cells and other highly glycolytic cells involved in aging and aging-related disease • The SIWA target is produced by glycolysis • Demonstrated targeting of senescent cells in aging-related diseases • Demonstrated targeting of cancer cellsRead more
day: Day Two